Chuanjuan Tao

This inventor holds 17 USPTO granted patents and 10 published patent applications and 6 EPO patents. Top assignees: Columbia University, Government of the United States of America, as Represented by the Secretary of Commerce. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chuanjuan Tao. Retrieved from https://idiyas.com/inventor/chuanjuan-tao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 10)

% Patents Active = 100.0

EPO Patents = 6 (Patent Applications = 12)

Average Co-Inventor Count = 8.8

ph-index = 4

Forward Citations = 81(Granted Patents)

Location History:

New York, NY (US) (2019 - 2023)
Fort Lee, NJ (US) (2021 - 2024)

Company Filing History:

Government of the United States of America, as Represented by the Secretary of Commerce

patents

where one patent can have more than one assignee

Years Active: 2019-2026

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12535477 - Single-molecule electronic multiplex nanopore immunoassays for biomarker detection (2026-01-27),

2. 12503730 - DETECTABLE NUCLEOTIDE ANALOGUES (2025-12-23),

3. 12337009 - Nucleotide derivatives and methods of use thereof (2025-06-24),

4. 12188086 - Nucleotide analogues and use thereof for nucleic acid sequencing and analysis preliminary class (2025-01-07),

5. 12173366 - DNA sequencing by synthesis using modified nucleotides and nanopore detection (2024-12-24),

6. 12006540 - Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis (2024-06-11),

7. 11999999 - Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis (2024-06-04),

8. 11959137 - Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis (2024-04-16),

9. 11795191 - Method of preparation of nanopore and uses thereof (2023-10-24),

10. 11499186 - DNA sequencing by synthesis using modified nucleotides and nanopore detection (2022-11-15),

11. 11266673 - Nucleotide derivatives and methods of use thereof (2022-03-08),

12. 11085076 - Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis (2021-08-10),

13. 10732183 - Method for detecting multiple predetermined compounds in a sample (2020-08-04),

14. 10718011 - Single molecule electronic multiplex SNP assay and PCR analysis (2020-07-21),

15. 10662463 - Polymer tagged nucleotides for single molecule electronic SNP assay (2020-05-26),

Title: Chuanjuan Tao: Innovator in Nucleic Acid Sequencing

Introduction

Chuanjuan Tao is a prominent inventor based in New York, NY, known for his significant contributions to the field of nucleic acid sequencing. With a total of 15 patents to his name, he has made remarkable advancements in the development of nucleotide derivatives and their applications.

Latest Patents

Among his latest patents, one notable invention is focused on nucleotide derivatives and methods of use thereof. This patent discloses compounds, compositions, and methods that facilitate the sequencing of nucleic acids. Another important patent involves nucleotide analogues and their use for nucleic acid sequencing and analysis. This invention provides various orthogonal nucleotide analogues and methods for utilizing combinations of these analogues for sequencing by synthesis.

Career Highlights

Chuanjuan Tao has had a distinguished career, working with esteemed institutions such as Columbia University and the Government of the United States of America, as represented by the Secretary of Commerce. His work has significantly impacted the scientific community and has paved the way for advancements in genetic research.

Collaborations

Throughout his career, Chuanjuan has collaborated with notable colleagues, including Jingyue Ju and Shiv R Kumar. These collaborations have further enhanced his research and innovation in the field.

Conclusion

Chuanjuan Tao's contributions to nucleic acid sequencing and his extensive patent portfolio highlight his role as a leading inventor in the field. His work continues to influence advancements in genetic research and technology.

Profile summary based on public USPTO records.